FDA-approved medications for chronic weight management include orlistat, phentermine/topiramate ER, naltrexone/bupropion ER, liraglutide 3 mg, semaglutide 2.4 mg, and tirzepatide
Ho and Petrou explained the signs of semaglutide overdose can resemble those of hypoglycemia, also known as low blood sugar
That anxiety is valid
Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period
[10] [22] Disease-modifying therapies commonly used in MS include: Injectable therapies : Interferon beta preparations (Avonex, Rebif, Betaseron) and glatiramer acetate (Copaxone) Oral agents : Fingolimod (Gilenya), dimethyl fumarate (Tecfidera), teriflunomide (Aubagio), siponimod (Mayzent), ozanimod (Zeposia), and cladribine (Mavenclad) Infusion therapies : Natalizumab (Tysabri), ocrelizumab (Ocrevus), alemtuzumab (Lemtrada) Subcutaneous injection : Ofatumumab (Kesimpta) No direct drug-drug interactions between tirzepatide and these DMTs have been identified in pharmacological studies
